It doesn't face patent expirations on key drugs for years (this is a result of the bad track record of Hassan's predecessors at inventing new medicines), and sugammadex, a new anesthesia drug that came from acquiring Organon, looks like a very important medicine.

FORBES: Schering Glitters, But Is It Gold?